Drug Co. Claims Licensee Breached ProQuin Deal
A specialty pharmaceutical company said Monday that a New Jersey drug company has failed to make good on a $10 million license fee payment and has not used commercially reasonable efforts...To view the full article, register now.
Already a subscriber? Click here to view full article